Floatz logo

72 assets in Burkitt Lymphoma

Therapeutic assets addressing Burkitt Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Nivestim
Burkitt Lymphoma
Fred Hutchinson Cancer CenterP4BBB (78)
Vincristine Sulfate
Burkitt Lymphoma
AIDS Malignancy ConsortiumP2BBB (76)
Cyclophosphamide
Burkitt Lymphoma
AIDS Malignancy ConsortiumP4BBB (74)
Cyclosporin A
Burkitt Lymphoma
Fred Hutchinson Cancer CenterP2BBB (74)
Adriamycin
Burkitt Lymphoma
AIDS Malignancy ConsortiumP4BBB (73)
Cytarabine
Burkitt Lymphoma
AIDS Malignancy ConsortiumP4BBB (73)
Etoposide
Burkitt Lymphoma
AIDS Malignancy ConsortiumP4BBB (73)
Fludarabine
Burkitt Lymphoma
City of Hope Medical CenterP2BBB (73)
Romidepsin
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2BBB (73)
Rituximab
Burkitt Lymphoma
AIDS Malignancy ConsortiumP4BBB (72)
(+)-Vincristine
Burkitt Lymphoma
AIDS Malignancy ConsortiumP4BBB (72)
Carboplatin
Burkitt Lymphoma
New York Medical CollegeP2BB (70)
Dexasone
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (70)
Methotrexate
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (70)
Bendamustine
Burkitt Lymphoma
National Cancer Institute (NCI)P2BB (69)
Camustine
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (69)
Isocyclophosphamide
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (69)
Prednisone
Burkitt Lymphoma
AIDS Malignancy ConsortiumP2BB (69)
Melphalan
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (68)
Lenalidomide
Burkitt Lymphoma
National Cancer Institute (NCI)P2BB (67)
Lomustine
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (66)
Vorinostat
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2BB (65)
Busulfanum
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2BB (64)
Clofarabine
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2BB (64)
Sirolimus
Burkitt Lymphoma
Masonic Cancer Center, University of MinnesotaP2BB (64)
Ibrutinib
Burkitt Lymphoma
National Cancer Institute (NCI)P2B (63)
Tacrolimus
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2B (63)
Humax-Cd20
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2B (62)
Idarubicin
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4B (62)
Obinutuzumab
Burkitt Lymphoma
Acepodia Biotech, Inc.P2B (62)
Venetoclax
Burkitt Lymphoma
Children's Hospital Medical Center, CincinnatiP2B (62)
Thiotepa
Burkitt Lymphoma
Fifth Affiliated Hospital, Sun Yat-Sen UniversityP2B (61)
Bortezomib
Burkitt Lymphoma
Rutgers, The State University of New JerseyP2B (60)
Nivolumab
Burkitt Lymphoma
National Cancer Institute (NCI)P2B (60)
Oxaliplatin
Burkitt Lymphoma
AIDS Malignancy ConsortiumP2B (60)
Pegfilgrastim
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2B (60)
Cladribine
Burkitt Lymphoma
Fifth Affiliated Hospital, Sun Yat-Sen UniversityP2B (58)
Allopurinol
Burkitt Lymphoma
Masonic Cancer Center, University of MinnesotaP2B (57)
Blinatumomab
Burkitt Lymphoma
National Cancer Institute (NCI)P1/2B (57)
Cart-19 Cells
Burkitt Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP3B (57)
Inotuzumab Ozogamicin
Burkitt Lymphoma
SWOG Cancer Research NetworkP1/2B (57)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
Burkitt Lymphoma
AIDS Malignancy ConsortiumP1/2CCC (54)
Brexucabtagene Autoleucel
Burkitt Lymphoma
Kite, A Gilead CompanyP2CCC (53)
Epcoritamab
Burkitt Lymphoma
AIDS Malignancy ConsortiumP2CCC (53)
Fludeoxyglucose
Burkitt Lymphoma
University of WashingtonP2CCC (53)
Mgta-456
Burkitt Lymphoma
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Sepantronium
Burkitt Lymphoma
Cothera Bioscience, IncP2CCC (53)
Treosulfan
Burkitt Lymphoma
Fred Hutchinson Cancer CenterP2CCC (53)
Zilovertamab Vedotin
Burkitt Lymphoma
Merck Sharp & Dohme LLCP1/2CCC (53)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer
Burkitt Lymphoma
National Cancer Institute (NCI)P2CCC (48)
Showing 1 to 50 of 72 assets
PreviousPage 1 of 2Next